HBR IdeaCast

CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

05.20.2021 - By Harvard Business ReviewPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and to create a database of genetic information for commercial and academic researchers to promote broader improvements to the healthcare system. She speaks with HBR's Editor-in-Chief Adi Ignatius about tackling challenges in an emerging industry.

More episodes from HBR IdeaCast